Literature DB >> 21703410

Cavia porcellus as a model for experimental infection by Trypanosoma cruzi.

Yagahira E Castro-Sesquen1, Robert H Gilman, Verónica Yauri, Noelia Angulo, Manuela Verastegui, Daniel E Velásquez, Charles R Sterling, Diana Martin, Caryn Bern.   

Abstract

The guinea pig (Cavia porcellus) is a natural reservoir for Trypanosoma cruzi but has seldom been used as an experimental infection model. We developed a guinea pig infection model for acute and chronic Chagas disease. Seventy-two guinea pigs were inoculated intradermally with 10(4) trypomastigotes of T. cruzi strain Y (experimental group); 18 guinea pigs were used as control group. Eight animals from the experimental group and two from the control group were sacrificed 5, 15, 20, 25, 40, 55, 115, 165, and 365 days after inoculation. During the acute phase (15 to 55 days), we observed parasitemia (with a peak on day 20) and positive IgM and IgG Western blots with anti-shed acute-phase antigen bands. The cardiac tissue showed vasculitis, necrosis (on days 40 to 55), moderate to severe inflammation, and abundant amastigote nests. Smaller numbers of amastigote nests were also present in kidney, brain, and other organs. In the early chronic phase (115 to 165 days), parasitemia disappeared and anti-T. cruzi IgG antibodies were still detectable. In cardiac tissue, the number of amastigote nests and the grade of inflammation decreased. In the chronic phase (365 days), the cardiac tissue showed vasculitis and fibrosis; detectable parasite DNA was associated with higher grades of inflammation. The experimental T. cruzi infection model in guinea pigs shows kinetics and pathologic changes similar to those of the human disease.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703410      PMCID: PMC3123796          DOI: 10.1016/j.ajpath.2011.03.043

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  60 in total

1.  Tissue tropism of different Trypanosoma cruzi strains.

Authors:  R C Melo; Z Brener
Journal:  J Parasitol       Date:  1978-06       Impact factor: 1.276

Review 2.  First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responses.

Authors:  Tom H M Ottenhoff; T Mark Doherty; Jaap T van Dissel; Peter Bang; Karen Lingnau; Ingrid Kromann; Peter Andersen
Journal:  Hum Vaccin       Date:  2010-12-01

3.  The Guinea pig placenta: model of placental growth dynamics.

Authors:  A Mess
Journal:  Placenta       Date:  2007-03-23       Impact factor: 3.481

4.  Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction.

Authors:  Alejandro G Schijman; Jaime Altcheh; Juan M Burgos; Miguel Biancardi; Margarita Bisio; Mariano J Levin; Héctor Freilij
Journal:  J Antimicrob Chemother       Date:  2003-08-13       Impact factor: 5.790

5.  Shift of excretory-secretory immunogens of Trypanosoma cruzi during human Chagas' disease.

Authors:  E E Jazín; A O Luquetti; A Rassi; A C Frasch
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 6.  First case of natural infection in pigs. Review of Trypanosoma cruzi reservoirs in Mexico.

Authors:  P M Salazar-Schettino; M I Bucio; M Cabrera; J Bautista
Journal:  Mem Inst Oswaldo Cruz       Date:  1997 Jul-Aug       Impact factor: 2.743

7.  The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease.

Authors:  J Antonio Marin-Neto; Anis Rassi; Alvaro Avezum; Antonio C Mattos; Anis Rassi; Carlos A Morillo; Sergio Sosa-Estani; Salim Yusuf
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

Review 8.  Animal models of human cardiovascular disease, heart failure and hypertrophy.

Authors:  G Hasenfuss
Journal:  Cardiovasc Res       Date:  1998-07       Impact factor: 10.787

9.  Experimental Chagas' disease in complement-deficient mice and guinea pigs.

Authors:  A P Dalmasso; J A Jarvinen
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

10.  Periurban Trypanosoma cruzi-infected Triatoma infestans, Arequipa, Peru.

Authors:  Michael Zachary Levy; Natalie M Bowman; Vivian Kawai; Lance A Waller; Juan Geny Cornejo del Carpio; Eleazar Cordova Benzaquen; Robert H Gilman; Caryn Bern
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883

View more
  12 in total

1.  Heterogeneous infectiousness in guinea pigs experimentally infected with Trypanosoma cruzi.

Authors:  Ricardo Castillo-Neyra; Katty Borrini Mayorí; Renzo Salazar Sánchez; Jenny Ancca Suarez; Sherrie Xie; Cesar Náquira Velarde; Michael Z Levy
Journal:  Parasitol Int       Date:  2015-10-22       Impact factor: 2.230

2.  Bottlenecks in domestic animal populations can facilitate the emergence of Trypanosoma cruzi, the aetiological agent of Chagas disease.

Authors:  Michael Z Levy; Aaron Tustin; Ricardo Castillo-Neyra; Tarub S Mabud; Katelyn Levy; Corentin M Barbu; Victor R Quispe-Machaca; Jenny Ancca-Juarez; Katty Borrini-Mayori; Cesar Naquira-Velarde; Richard S Ostfeld
Journal:  Proc Biol Sci       Date:  2015-07-07       Impact factor: 5.349

3.  Domestic Pig (Sus scrofa) as an Animal Model for Experimental Trypanosoma cruzi Infection.

Authors:  Verónica Yauri; Yagahira E Castro-Sesquen; Manuela Verastegui; Noelia Angulo; Fernando Recuenco; Ines Cabello; Edith Malaga; Caryn Bern; Cesar M Gavidia; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2016-02-29       Impact factor: 2.345

Review 4.  Translational challenges of animal models in Chagas disease drug development: a review.

Authors:  Eric Chatelain; Nandini Konar
Journal:  Drug Des Devel Ther       Date:  2015-08-19       Impact factor: 4.162

5.  Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Carolina Mejia; Daniel E Clark; Jeong Choi; Melissa J Reimer-McAtee; Rosario Castro; Edward Valencia-Ayala; Jorge Flores; Natalie Bowman; Ricardo Castillo-Neyra; Faustino Torrico; Lance Liotta; Caryn Bern; Alessandra Luchini
Journal:  PLoS Negl Trop Dis       Date:  2016-02-26

6.  Cell death and serum markers of collagen metabolism during cardiac remodeling in Cavia porcellus experimentally infected with Trypanosoma cruzi.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Henry Paico; Verónica Yauri; Noelia Angulo; Fredy Ccopa; Caryn Bern
Journal:  PLoS Negl Trop Dis       Date:  2013-02-07

7.  Detection of soluble antigen and DNA of Trypanosoma cruzi in urine is independent of renal injury in the guinea pig model.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Verónica Yauri; Jaime Cok; Noelia Angulo; Hermes Escalante; Caryn Bern
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

Review 8.  Quality of Reporting and Adherence to ARRIVE Guidelines in Animal Studies for Chagas Disease Preclinical Drug Research: A Systematic Review.

Authors:  Julián Ernesto Nicolás Gulin; Daniela Marisa Rocco; Facundo García-Bournissen
Journal:  PLoS Negl Trop Dis       Date:  2015-11-20

9.  Characterization of guinea pig antibody responses to salivary proteins of Triatoma infestans for the development of a triatomine exposure marker.

Authors:  Veronika Dorňáková; Renzo Salazar-Sanchez; Katty Borrini-Mayori; Oscar Carrion-Navarro; Michael Z Levy; Günter A Schaub; Alexandra Schwarz
Journal:  PLoS Negl Trop Dis       Date:  2014-04-03

10.  The role of fat on cardiomyopathy outcome in mouse models of chronic Trypanosoma cruzi infection.

Authors:  Paul Zaki; Elisa Lbc Domingues; Farhad M Amjad; Maiara B Narde; Karolina R Gonçalves; Mirelle L Viana; Heberth de Paula; Wanderson G de Lima; Huan Huang; Maria T Bahia; Philipp E Sherer; Fabiane M Dos Santos; Louis M Weiss; Herbert B Tanowitz
Journal:  Parasitol Res       Date:  2020-03-24       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.